Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Health Care · ·
$3.45
▼ $0.01 (-0.1%)
Market data updated: 09/28 06:23 PM
Fundamentals updated: 09/28/2026
News analyzed: 09/28/2026
Market Cap
$247.52M
Day Range
$3.34 - $3.47
52-Week Range
$2.83 - $9.29
Beta
—
Next Earnings
04.11.2026
Support
$2.83
Resistance
$3.61
SIGA is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.
-62.4% (1Y)
Strengths: 15/28 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $8.49 vs. price $3.45 (+146.5%)
Fair Value
Biggest negative driver
Operating margin stability
Operating margin is eroding over time
Quality
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
57
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
26
Quality
42
Value
67
Momentum
65
Risk
40
Sentiment
56
Fundamental
76
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of SIGA Technologies Inc. has primarily focused on its financial performance and strategic challenges. The company reported a 65% drop in profits for Q2 2026, though it maintained positive earnings and paid a special dividend, signaling financial stability despite revenue declines. Key concerns include the approaching expiration of its BARDA TPOXX contract, raising uncertainty about future revenue streams amid rising measles outbreaks in the U.S. Investor attention also centered on its Q2 earnings call, where leadership discussed revenue growth and long-term strategies amid shifting market conditions.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about SIGA Technologies Inc.. News trend score: 56. Reason: 3 of the last 17 articles are positive, versus 2 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
38
🎯 Conviction (vs. Emotion)
34
Psychology
46
Fundamentals
76
Technical
65
Valuation
67
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price, sentiment, and valuation keep confirming each other upward while the actual fundamentals deteriorate.
The price rise has far outpaced the actual improvement in fundamental data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price (3M)
-5%
Market Narrative
50
Fundamental Reality
34
Narrative Gap
+16
🔀 Weak-Conviction Rally
Price is moving, but not accompanied by a matching rise in news attention/sentiment.
🧠 StockIQ Psychologist
The market’s dominant Loss Aversion (40) reflects a defensive stance after a steep 3-month drop (-23.5%), with traders hesitant to exit despite elevated volume. FOMO (35) coexists due to momentum (+5.8% ROC) and neutral RSI (61), but it’s tempered by valuation gaps (-62% DCF) and peer underperformance. Confirmation Bias (9) may reinforce narratives over deteriorating fundamentals (revenue/margins). The key question: *Will traders prioritize risk-off behavior or chase momentum?*
Updated: 09/09/2026, 08:20 AM
What could change this?
👥 What the crowd believes
"Revenue and profit both cratered from a year ago"
"paid out a special dividend, despite 65% profit drop"
"BARDA TPOXX contract nearing exhaustion, renewal uncertain"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 100/100
🔴 Weakest match
Morgan Housel — 0/100
🗣️ Why do they disagree?
The stark divide in verdicts for SIGA reflects deep methodological contrasts between value, trend-following, and behavioral frameworks. Benjamin Graham and his Defensive Investor approach see strong fundamentals—high liquidity and statistical discounts—making it a compelling buy, while his Enterprising Investor variant still endorses it as a rare bargain. In contrast, trend-followers like Jesse Livermore and Jack Schwager reject it outright, dismissing its downtrend as a violation of core rules, while Howard Marks’ cycle-aware lens suggests it’s merely mid-cycle, not a speculative bubble. Meanwhile, behavioral economists like Thorstein Veblen and Morgan Housel flag it as a speculative growth play or volatile trap, respectively, while Philip Fisher and Peter Lynch’s growth-focused criteria leave it unconvincing. The split underscores how SIGA’s volatility and speculative traits appeal to disciplined value hunters but repel trend traders and behavioral skeptics.
Walter Bagehot
Lombard Street (1873)
🟢 100
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 96
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 81
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 78
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟢 71
Deep statistical discount — a real Enterprising Investor candidate
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 64
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 45
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 41
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 39
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🔴 29
Weak case — Malkiel/Bogle would say a low-cost index is the simpler bet
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 28
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 28
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 26
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 8
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 7
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 0
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Based on the last 286 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (7 bullish · 3 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A pattern consistent with an early/mid accumulation phase — a trading range after a decline with declining volume.
Medium confidence
$2.83
Range Bottom
$3.61
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
68.6%
Operating Margin
25.1%
Net Margin
24.6%
EBITDA Margin
25.7%
ROE
11.7%
ROA
10.6%
ROIC
—
EPS
$0.33
Cash
$154.97M
Total Debt
—
Current Ratio
11.83
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 7.4.2026 | $0.600 |
| 6.4.2026 | $0.600 |
| 29.4.2025 | $0.600 |
| 28.4.2025 | $0.600 |
| 25.3.2024 | $0.600 |
| 24.3.2024 | $0.600 |
| 15.5.2023 | $0.450 |
| 14.5.2023 | $0.450 |
| 16.5.2022 | $0.450 |
| 15.5.2022 | $0.450 |
How is Fair Value calculated? →
Current Price
$3.45
Estimated Fair Value (DCF)
$8.49
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+146.5%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
-2.1%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -2.1% | $42.20M | $38.72M |
| 2 | -1.0% | $41.79M | $35.18M |
| 3 | 0.2% | $41.87M | $32.33M |
| 4 | 1.3% | $42.43M | $30.06M |
| 5 | 2.5% | $43.49M | $28.27M |
Base FCF (last actual year)
$43.12M
Terminal Value
$685.87M
Present Value of Terminal Value
$445.77M
Enterprise Value
$610.32M
Net Debt
$0
Equity Value
$610.32M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$2.77
Tangible Book Value per Share (Tangible NAV)
$2.75
Sentiment based on basic keywords (not AI) — 3 positive, 12 neutral, 2 negative out of the last 17 articles.
Insider Monkey · 6.9.2026
Yahoo · 6.9.2026
SeekingAlpha · 1.9.2026
Motley Fool · 14.8.2026
Moby · 7.8.2026
Benzinga · 7.8.2026
MarketBeat · 7.8.2026
SeekingAlpha · 7.8.2026
GuruFocus.com · 7.8.2026
GlobeNewswire · 6.8.2026
Benzinga · 6.8.2026
GlobeNewswire · 30.7.2026
SeekingAlpha · 28.7.2026
Simply Wall St. · 30.6.2026
Simply Wall St. · 22.5.2026
Simply Wall St. · 15.5.2026
Simply Wall St. · 14.5.2026
SIGA Technologies Inc. (SIGA) currently has a StockIQ AI score of 57/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
SIGA currently scores 57/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, SIGA's estimated fair value is $8.49, which is 146.5% above the current price of $3.45. This is one valuation model among several signals in the fair-value category, not a price target.
SIGA's technical score is 65/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $8.49 vs. price $3.45 (+146.5%); Current ratio: 11.83; Price is above the 50-day average.
Based on the real signals StockIQ computed: Operating margin is eroding over time; ATR: 4.4% of price; Calmar: -0.17 (3y annualized return -13.0% / max drawdown 76.0%).
Yes — SIGA has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Nabel Gary J. | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| Nemirovsky Julian | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| DURNAN JAYMIE A | Grant/Award from Employer | 9.6.2026 | 34,169 | +34,169 | — |
| Phillips Holly L. | Grant/Award from Employer | 9.6.2026 | 34,169 | +34,169 | — |
| Ford Harold Eugene Jr. | Grant/Award from Employer | 9.6.2026 | 34,169 | +34,169 | — |
| Ford Harold Eugene Jr. | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| KEANE JOHN M | Exercise of Derivative Securities | 9.6.2026 | 24,116 | +24,116 | — |
| Nemirovsky Julian | Exercise of Derivative Securities | 9.6.2026 | 24,116 | +24,116 | — |
| Marshall Joseph W III | Grant/Award from Employer | 9.6.2026 | 34,169 | +34,169 | — |
| Phillips Holly L. | Exercise of Derivative Securities | 9.6.2026 | 24,116 | +24,116 | — |
| Ford Harold Eugene Jr. | Exercise of Derivative Securities | 9.6.2026 | 24,116 | -24,116 | — |
| KEANE JOHN M | Grant/Award from Employer | 9.6.2026 | 34,169 | +34,169 | — |
| Phillips Holly L. | Exercise of Derivative Securities | 9.6.2026 | 24,116 | -24,116 | — |
| KEANE JOHN M | Exercise of Derivative Securities | 9.6.2026 | 24,116 | -24,116 | — |
| Ford Harold Eugene Jr. | Exercise of Derivative Securities | 9.6.2026 | 24,116 | +24,116 | — |
| Phillips Holly L. | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| KEANE JOHN M | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| Marshall Joseph W III | Exercise of Derivative Securities | 9.6.2026 | 24,116 | -24,116 | — |
| Marshall Joseph W III | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| Marshall Joseph W III | Exercise of Derivative Securities | 9.6.2026 | 24,116 | +24,116 | — |
| Nabel Gary J. | Exercise of Derivative Securities | 9.6.2026 | 24,116 | -24,116 | — |
| Nabel Gary J. | Exercise of Derivative Securities | 9.6.2026 | 24,116 | +24,116 | — |
| Nabel Gary J. | Grant/Award from Employer | 9.6.2026 | 34,169 | +34,169 | — |
| DURNAN JAYMIE A | Disposition to the Company | 9.6.2026 | 7,235 | -7,235 | $4.39 |
| Nemirovsky Julian | Exercise of Derivative Securities | 9.6.2026 | 24,116 | -24,116 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
3,729,992 shares short as of 2026-09-15 · vs. 3,550,706 on 2026-08-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
50.4% of trading volume this week was short selling, vs. 37.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology